GD
Therapeutic Areas
Grove Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Bionic Biologics Platform | Oncology, Neurodegeneration, Rare Diseases | Pre-clinical |
| MYC/KRAS Degrader Program | Oncology | Pre-clinical |
| KEAP1/NRF2 Program | Myocardial Infarction | Pre-clinical |